Association Between C‐Reactive Protein–Triglyceride Glucose Index and All‐Cause and Cardiovascular Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–4
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/6690501 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 30.07.2026. Verfasst von Siqi Yi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital …. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial People's Hospital, Special Project for Research and Development in Key areas of Guangdong Province.
Abstract (Originalsprache)
Objective
Advanced cardiovascular–kidney–metabolic (CKM) syndrome corresponds to an elevated risk of mortality. The C‐reactive protein–triglyceride glucose index (CTI) reflects both insulin resistance and inflammation, processes that are crucial to CKM progression. However, it remains uncertain whether CTI is linked to mortality risk and how this relationship may vary across different CKM progression stages.
Methods
A total of 8314 participants were drawn from American adults. Participants were then grouped by advanced CKM stages. CTI was calculated as 0.412 × Ln (CRP [mg/L]) + Ln (TG [mg/dl] × FBG [mg/dl])/2. The endpoints focused on all‐cause and cardiovascular mortality. Associations of CTI with advanced CKM stages and mortality were examined using logistic and Cox regression models, respectively.
Results
The highest CTI quartile (Q4) exhibited a markedly greater prevalence of advanced CKM stages relative to Q1 ( p < 0.001). During a median follow‐up of 152 months, 1606 participants died, including 475 cardiovascular deaths. Each SD increase in CTI was associated with a 35% higher risk of all‐cause mortality (95% CI: 1.24–1.48) and a 40% higher risk of cardiovascular mortality (95% CI: 1.20–1.62). Similarly, compared with Q1, participants in Q4 of CTI had higher risks of all‐cause mortality (HR = 1.82, 95% CI: 1.46–2.27) and cardiovascular mortality (HR = 2.29, 95% CI: 1.56–3.34), with homogeneous associations across different CKM stages (interaction p > 0.05).
Conclusion
Higher CTI levels were accompanied by a greater prevalence of advanced CKM stages and were associated with increased risks of all‐cause and cardiovascular mortality across CKM stages. CTI may provide complementary information for mortality‐risk assessment although further validation is needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,…
- School of Medicine, South China University of Technology, Guangzhou, China, scut.edu.cn.
ORCID-Profile: Siqi Yi, Weida Qiu, Yingqing Feng
Förderung
- Guangdong Provincial People's Hospital
- Special Project for Research and Development in Key areas of Guangdong Province
Zitieren
APA
Yi, S., Qiu, W., Zhu, Y., Wu, S., Zheng, H., Huang, Q., Feng, Y., & Wu, Y. (2026). Association Between C‐Reactive Protein–Triglyceride Glucose Index and All‐Cause and Cardiovascular Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–4. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/6690501
Vancouver
Yi S, Qiu W, Zhu Y, Wu S, Zheng H, Huang Q, et al. Association Between C‐Reactive Protein–Triglyceride Glucose Index and All‐Cause and Cardiovascular Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–4. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/6690501
BibTeX
@article{Yi2026,
author = {Yi, Siqi and Qiu, Weida and Zhu, Yanchen and Wu, Shiping and Zheng, He and Huang, Qiujin and Feng, Yingqing and Wu, Ying},
title = {Association Between C‐Reactive Protein–Triglyceride Glucose Index and All‐Cause and Cardiovascular Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–4},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/6690501}
}
EUVIMED